Skip to main content

Henry Schein Value Stock - Dividend - Research Selection

Henry schein

ISIN: US8064071025 , WKN: 897961

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

We believe we are the world’s largest provider of health care products and services primarily to office-based dental, animal health and medical practitioners.  We serve more than 1 million customers worldwide including dental practitioners and laboratories, animal health clinics and physician practices, as well as government, institutional health care clinics and other alternate care clinics.  We believe that we have a strong brand identity due to our more than 84 years of experience distributing health care products.

 

We are headquartered in Melville, New York, employ more than 21,000 people (of which more than 10,500 are based outside the United States) and have operations or affiliates in 33 countries, including the United States, Australia, Austria, Belgium, Brazil, Canada, Chile, China, the Czech Republic, Denmark, France, Germany, Hong Kong SAR, Iceland, Ireland, Israel, Italy, Japan, Luxembourg, Malaysia, the Netherlands, New Zealand, Norway, Poland, Portugal, Romania, Slovakia, South Africa, Spain, Sweden, Switzerland, Thailand and the United Kingdom.

 

We offer a comprehensive selection of products and services and value-added solutions for operating efficient practices and delivering high quality care.  We operate through a centralized and automated distribution network with a selection of more than 120,000 branded products and Henry Schein private brand products in stock, as well as more than 180,000 additional products available as special order items.  We also offer our customers exclusive, innovative technology solutions, including practice management software and e-commerce solutions, as well as a broad range of financial services.

 

We have established over 4.5 million square feet of space in 62 strategically located distribution centers around the world to enable us to better serve our customers and increase our operating efficiency.  This infrastructure, together with broad product and service offerings at competitive prices, and a strong commitment to customer service, enables us to be a single source of supply for our customers’ needs.  Our infrastructure also allows us to provide convenient ordering and rapid, accurate and complete order fulfillment.

 

We conduct our business through two reportable segments: (i) health care distribution and (ii) technology and value-added services.  These segments offer different products and services to the same customer base. 

 

The health care distribution reportable segment aggregates our global dental, animal health and medical operating segments.  This segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.  Our global dental group serves office-based dental practitioners, dental laboratories, schools and other institutions.  Our global animal health group serves animal health practices and clinics.  Our global medical group serves office-based medical practitioners, ambulatory surgery centers, other alternate-care settings and other institutions. 

 

Our technology and value-added services group provides software, technology and other value-added services to health care practitioners.  Our technology group offerings include practice management software systems for dental and medical practitioners and animal health clinics.  Our value-added practice solutions include financial services on a non-recourse basis, e-services, practice technology, network and hardware services, as well as continuing education services for practitioners.

 

Source: www.sec.gov

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Henry Schein to Webcast First Quarter 2026 Conference Call on Tuesday, May 5, 2026, at 8: 00 A.M. ET

2026-04-21
Henry Schein, Inc. , the world’s largest provider of healthcare solutions to office-based dental and medical practitioners, announced today that it will release its first quarter 2026 financial...

McKesson Stock: A Compounding Engine Facing Its Critical Test

2026-04-20
McKesson’s net income grew at an average rate of 14.4% over the last three years, yet its earnings per share (EPS) increased by 19.6% annually during that same window. This 5.2% gap represents the additional value management captured for shareholders through a consistent strategy.

Why Henry Schein (HSIC) is Poised to Beat Earnings Estimates Again

2026-04-17
Henry Schein (HSIC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Marvell upgraded, Trade Desk downgraded: Wall Street's top analyst calls

2026-03-06
Marvell upgraded, Trade Desk downgraded: Wall Street's top analyst calls

3 Value Stocks We Steer Clear Of

2026-04-16
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.

This Dick's Sporting Goods Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

2026-04-16
Top analysts change outlook on top names, check analyst ratings page for all changes. Keybanc initiated Overweight rating on KALU with $170 PT.

BTIG Initiates Coverage On Henry Schein with Neutral Rating

2026-04-16
BTIG analyst David Larsen initiates coverage on Henry Schein (NASDAQ:HSIC) with a Neutral rating.

Cloudflare upgraded, SolarEdge downgraded: Wall Street's top analyst calls

2026-04-15
Cloudflare upgraded, SolarEdge downgraded: Wall Street's top analyst calls

Citigroup Initiates Coverage On Henry Schein with Buy Rating, Announces Price Target of $100

2026-04-15
Citigroup analyst Daniel Grosslight initiates coverage on Henry Schein (NASDAQ:HSIC) with a Buy rating and announces Price Target of $100.

3 Reasons HSIC is Risky and 1 Stock to Buy Instead

2026-04-14
Over the past six months, Henry Schein has been a great trade, beating the S&P 500 by 17.3%. Its stock price has climbed to $75.99, representing a healthy 19.9% increase. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.